Genetic and clinical landscape of ER + /PR- breast cancer in China

Genetic and clinical landscape of ER + /PR- breast cancer in China

Abstract Background Estrogen receptor-positive and progesterone receptor-negative (ER + /PR-) breast cancer comprise a special type. More than 10% breast cancer patients belonged to ER + /PR-. Methods In order to better understand this patient population, we utilized a unique dataset from China, exa...

Full description

Bibliographic Details
Main Authors: Danian Dai, Hongmei Wu, Hongkai Zhuang, Rong Chen, Cheng Long, Bo Chen
Format: Article
Language:English
Published: BMC 2023-12-01
Series:BMC Cancer
Subjects:
Breast cancer
Progesterone receptor
Estrogen receptor
NGS
MammaPrint
Online Access:https://doi.org/10.1186/s12885-023-11643-2

Internet

https://doi.org/10.1186/s12885-023-11643-2

Similar Items